Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Wade

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of Gastroenterology and Hepatology|December 19, 2023
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of carePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Digestive Diseases and Sciences|May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment CohortPaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of General Internal Medicine|January 21, 2025
Medical Students' Observations of High Value and Potentially Wasteful Care Behaviors Modeled During Clinical RotationsAmanda Wade, Meher Kalkat, Colin Uyeki, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
AIDS Research and Therapy|December 6, 2022
Successful expanded clinic network collaboration and patient tracing for retention in HIV careShivani Bhatt, Mellissa Bryant, Helen Lau, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
BMJ Open|July 3, 2024
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocolJoseph S Doyle, Katherine Heath, Imogen Elsum, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2025
Surviving Hepatitis C-Understanding Death and Survival Beyond CurePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of Gastroenterology and Hepatology|December 19, 2023
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of carePaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Digestive Diseases and Sciences|May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment CohortPaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of General Internal Medicine|January 21, 2025
Medical Students' Observations of High Value and Potentially Wasteful Care Behaviors Modeled During Clinical RotationsAmanda Wade, Meher Kalkat, Colin Uyeki, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
AIDS Research and Therapy|December 6, 2022
Successful expanded clinic network collaboration and patient tracing for retention in HIV careShivani Bhatt, Mellissa Bryant, Helen Lau, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
BMJ Open|July 3, 2024
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocolJoseph S Doyle, Katherine Heath, Imogen Elsum, et al.
Pageof 2